United States securities and exchange commission logo August 17, 2021 Shane Schaffer Chief Executive Officer Cingulate Inc. 1901 W. 47th Place Kansas City, KS 66205 Re: Cingulate Inc. Amendment No. 2 to Draft Registration Statement on Form S-1 Submitted August 13, 2021 CIK No. 0001862150 Dear Mr. Schaffer: We have reviewed your amended draft registration statement and have the following comment. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to this comment and your amended draft registration statement or filed registration statement, we may have additional comments. Amendment No. 2 to Draft Registration Statement on Form S-1 submitted August 13, 2021 Business Recently Launched Products Lack Meaningful Clinical Innovation, page 83 1. Please disclose the source of all information contained in the above entitled chart on page 83. You may contact Gary Newberry at 202-551-3761 or Daniel Gordon at 202-551-3486 if you have questions regarding comments on the financial statements and related matters. Please contact Dillon Hagius at 202-551-7967 or Laura Crotty at 202-551-7614 with any other questions. Shane Schaffer Cingulate Inc. August 17, 2021 Page 2 Sincerely, FirstName LastNameShane Schaffer Division of Corporation Finance Comapany NameCingulate Inc. Office of Life Sciences August 17, 2021 Page 2 cc: Steven Skolnick FirstName LastName